Artiva Biotherapeutics (ARTV) Non-cash Items (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Non-cash Items data on file, last reported at $19.7 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $19.7 million, up 1669.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.7 million (up 1669.06% YoY), and the FY2025 annual result was $412000.0, down 94.21% from the prior year.
• Non-cash Items grew to $19.7 million in Q1 2026 per ARTV's latest filing, from $412000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $19.7 million in Q1 2026 and troughed at $214000.0 in Q4 2023.
• A 4-year average of $4.8 million and a median of $1.1 million in 2025 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items soared 3226.17% in 2024, then sank 94.21% in 2025.
• A 4-year view of Non-cash Items shows it stood at $214000.0 in 2023, then soared by 3226.17% to $7.1 million in 2024, then slumped by 94.21% to $412000.0 in 2025, then surged by 4681.55% to $19.7 million in 2026.
• Business Quant data shows ARTV's Non-cash Items at $19.7 million in Q1 2026, $412000.0 in Q4 2025, and $7.4 million in Q3 2025.